Form 4 for CLB Core Laboratories Inc. /DE/
Accepted 2023-12-04 00:00:00 ET · period of report 2023-12-01 · accession 0000950170-23-067809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-04 | 2023-12-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | F - Tax | $18.07 | -62 | 6,193 | -1.0% | -$1,120 |
| D | 2023-12-04 | 2023-12-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | +160 | 6,255 | +3% | $0 |
| D | 2023-12-04 | 2023-12-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -160 | 4,370 | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | F | D | 62 | $18.07 | 6,192.62 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-01 | M | A | 160 | $0.00 | 6,254.62 | D | — | — | |
| 3 | Derivative | Restricted Shares | 2023-12-01 | M | D | 160 | $0.00 | 4,370 | D | — · — to — | 160 Common Stock | (F2) Multiple restricted share grants are included in this total. (F1) The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. |